SNYR

SEC source: 0001903189-26-000002 · primary_doc.xml · derivative · entry 2

Baumeler Alfred · CIK 0001903189 · Director · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, par value $0.00001 per share · 150,000 shares

Expires 2030-09-18

F2 · price: The reduction in the exercise price of the Original Option constitutes a material modification and is deemed, for purposes of Section 16, to involve a cancellation of the Original Option and the grant of a new option in its place. The new option vests on the same schedule as the Original Option, as if it had been granted on the Original Grant Date, and expires on the five-year anniversary of the Original Grant Date.

F1 · derivative.exercise_date: One-third (1/3) of this option grant (the "Original Option") vests on the first anniversary of September 18, 2025 (the "Original Grant Date"), and the remaining two-thirds (2/3) vest in equal monthly installments over the twenty-four (24) months thereafter, in each case subject to the reporting person's continued service with the Company.

SEC source: 0001903189-26-000002 · primary_doc.xml · derivative · entry 1

Baumeler Alfred · CIK 0001903189 · Director · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock, par value $0.00001 per share · 150,000 shares

Expires 2030-09-18

F2 · price: The reduction in the exercise price of the Original Option constitutes a material modification and is deemed, for purposes of Section 16, to involve a cancellation of the Original Option and the grant of a new option in its place. The new option vests on the same schedule as the Original Option, as if it had been granted on the Original Grant Date, and expires on the five-year anniversary of the Original Grant Date.

F1 · derivative.exercise_date: One-third (1/3) of this option grant (the "Original Option") vests on the first anniversary of September 18, 2025 (the "Original Grant Date"), and the remaining two-thirds (2/3) vest in equal monthly installments over the twenty-four (24) months thereafter, in each case subject to the reporting person's continued service with the Company.

SEC source: 0001903192-26-000002 · primary_doc.xml · derivative · entry 2

Fickett Jaime · CIK 0001903192 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, par value $0.00001 per share · 150,000 shares

Expires 2030-09-18

F2 · price: The reduction in the exercise price of the Original Option constitutes a material modification and is deemed, for purposes of Section 16, to involve a cancellation of the Original Option and the grant of a new option in its place. The new option vests on the same schedule as the Original Option, as if it had been granted on the Original Grant Date, and expires on the five-year anniversary of the Original Grant Date.

F1 · derivative.exercise_date: One-third (1/3) of this option grant (the "Original Option") vests on the first anniversary of September 18, 2025 (the "Original Grant Date"), and the remaining two-thirds (2/3) vest in equal monthly installments over the twenty-four (24) months thereafter, in each case subject to the reporting person's continued service with the Company.

SEC source: 0001903192-26-000002 · primary_doc.xml · derivative · entry 1

Fickett Jaime · CIK 0001903192 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock, par value $0.00001 per share · 150,000 shares

Expires 2030-09-18

F2 · price: The reduction in the exercise price of the Original Option constitutes a material modification and is deemed, for purposes of Section 16, to involve a cancellation of the Original Option and the grant of a new option in its place. The new option vests on the same schedule as the Original Option, as if it had been granted on the Original Grant Date, and expires on the five-year anniversary of the Original Grant Date.

F1 · derivative.exercise_date: One-third (1/3) of this option grant (the "Original Option") vests on the first anniversary of September 18, 2025 (the "Original Grant Date"), and the remaining two-thirds (2/3) vest in equal monthly installments over the twenty-four (24) months thereafter, in each case subject to the reporting person's continued service with the Company.

SEC source: 0001626921-26-000002 · primary_doc.xml · derivative · entry 2

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Kenek Brands Inc.

Disclosed balance after: 0

Underlying: Common Stock, par value $0.00001 per share · 750,000 shares

Expires 2030-09-18

F2 · price: The reduction in the exercise price of the Original Option constitutes a material modification and is deemed, for purposes of Section 16, to involve a cancellation of the Original Option and the grant of a new option in its place. The new option vests on the same schedule as the Original Option, as if it had been granted on the Original Grant Date, and expires on the five-year anniversary of the Original Grant Date.

F1 · derivative.exercise_date: One-third (1/3) of this option grant (the "Original Option") vests on the first anniversary of September 18, 2025 (the "Original Grant Date"), and the remaining two-thirds (2/3) vest in equal monthly installments over the twenty-four (24) months thereafter, in each case subject to the reporting person's continued service with the Company.

F3 · ownership.direct: The reported securities are owned directly by Kenek Brands Inc., which is controlled by the reporting person. The reporting person is the indirect beneficial owner of the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001626921-26-000002 · primary_doc.xml · derivative · entry 1

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Kenek Brands Inc.

Disclosed balance after: 750,000

Underlying: Common Stock, par value $0.00001 per share · 750,000 shares

Expires 2030-09-18

F2 · price: The reduction in the exercise price of the Original Option constitutes a material modification and is deemed, for purposes of Section 16, to involve a cancellation of the Original Option and the grant of a new option in its place. The new option vests on the same schedule as the Original Option, as if it had been granted on the Original Grant Date, and expires on the five-year anniversary of the Original Grant Date.

F1 · derivative.exercise_date: One-third (1/3) of this option grant (the "Original Option") vests on the first anniversary of September 18, 2025 (the "Original Grant Date"), and the remaining two-thirds (2/3) vest in equal monthly installments over the twenty-four (24) months thereafter, in each case subject to the reporting person's continued service with the Company.

F3 · ownership.direct: The reported securities are owned directly by Kenek Brands Inc., which is controlled by the reporting person. The reporting person is the indirect beneficial owner of the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0002089979-26-000001 · primary_doc.xml · nonDerivative · entry 1

Thompson Teresa Brigid · CIK 0002089979 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,824

F1 · balance_after: The reported securities are restricted stock units ("RSU"). Each RSU represents a contingent right to receive one share of common stock, par value $0.00001 per share, of Synergy CHC Corp. (the "Issuer"), subject to the conditions set forth in the applicable RSU award agreement and Issuer's 2024 Equity Incentive Plan, as amended. The RSUs vested in full on the grant date.

SEC source: 0001782072-26-000001 · primary_doc.xml · nonDerivative · entry 1

Kaushal Nitin · CIK 0001782072 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 306,433

F1 · balance_after: The reported securities are restricted stock units ("RSU"). Each RSU represents a contingent right to receive one share of common stock, par value $0.00001 per share, of Synergy CHC Corp. (the "Issuer"), subject to the conditions set forth in the applicable RSU award agreement and Issuer's 2024 Equity Incentive Plan, as amended. The RSUs vested in full on the grant date.

SEC source: 0001903189-25-000002 · primary_doc.xml · derivative · entry 1

Baumeler Alfred · CIK 0001903189 · Director · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock, par value $0.00001 per share · 150,000 shares

Expires 2030-09-18

F1 · derivative.exercise_date: One-third (1/3) of this option grant vests on the first anniversary of the date of grant, and the remaining two-thirds (2/3) vest in equal monthly installments over the following twenty-four (24) months, subject to the reporting person's continued service with the Company.

SEC source: 0001903192-25-000003 · primary_doc.xml · derivative · entry 1

Fickett Jaime · CIK 0001903192 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock, par value $0.00001 per share · 150,000 shares

Expires 2030-09-18

F1 · derivative.exercise_date: One-third (1/3) of this option grant vests on the first anniversary of the date of grant, and the remaining two-thirds (2/3) vest in equal monthly installments over the following twenty-four (24) months, subject to the reporting person's continued service with the Company.

SEC source: 0001626921-25-000003 · primary_doc.xml · derivative · entry 1

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Kenek Brands Inc.

Disclosed balance after: 750,000

Underlying: Common Stock, par value $0.00001 per share · 750,000 shares

Expires 2030-09-18

F1 · derivative.exercise_date: One-third (1/3) of this option grant vests on the first anniversary of the date of grant, and the remaining two-thirds (2/3) vest in equal monthly installments over the following twenty-four (24) months, subject to the reporting person's continued service with the Company.

F2 · ownership.direct: The reported securities are owned directly by Kenek Brands Inc., which is controlled by the reporting person. The reporting person is the indirect beneficial owner of the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001474506-25-000145 · primary_doc.xml · nonDerivative · entry 24

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 410,507

SEC source: 0001474506-25-000145 · primary_doc.xml · nonDerivative · entry 23

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 410,407

F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) through (21) to this Form 4.

F21 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.653 to $3.689, inclusive.

SEC source: 0001474506-25-000145 · primary_doc.xml · nonDerivative · entry 22

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 410,157

F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) through (21) to this Form 4.

F20 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.830 to $3.935, inclusive.

SEC source: 0001474506-25-000145 · primary_doc.xml · nonDerivative · entry 21

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 409,807

F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) through (21) to this Form 4.

F19 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.761 to $3.910, inclusive.

SEC source: 0001474506-25-000145 · primary_doc.xml · nonDerivative · entry 20

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 409,507

F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) through (21) to this Form 4.

F18 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.465 to $3.583, inclusive.

SEC source: 0001474506-25-000145 · primary_doc.xml · nonDerivative · entry 19

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 409,207

F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) through (21) to this Form 4.

F17 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.137 to $3.277, inclusive.

SEC source: 0001474506-25-000145 · primary_doc.xml · nonDerivative · entry 18

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 408,457

F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) through (21) to this Form 4.

F16 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.147 to $3.230, inclusive.

SEC source: 0001474506-25-000145 · primary_doc.xml · nonDerivative · entry 17

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 407,057

F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) through (21) to this Form 4.

F15 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.087 to $3.341, inclusive.

SEC source: 0001474506-25-000145 · primary_doc.xml · nonDerivative · entry 16

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 406,657

F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) through (21) to this Form 4.

F14 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.336 to $3.370, inclusive.

SEC source: 0001474506-25-000145 · primary_doc.xml · nonDerivative · entry 15

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 405,857

F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) through (21) to this Form 4.

F13 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.240 to $3.327, inclusive.

SEC source: 0001474506-25-000145 · primary_doc.xml · nonDerivative · entry 14

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 405,157

F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) through (21) to this Form 4.

F12 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.197 to $3.236, inclusive.

SEC source: 0001474506-25-000145 · primary_doc.xml · nonDerivative · entry 13

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 403,407

F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) through (21) to this Form 4.

F11 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.118 to $3.274, inclusive.

SEC source: 0001474506-25-000145 · primary_doc.xml · nonDerivative · entry 12

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 399,657

F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) through (21) to this Form 4.

F10 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.005 to $3.120, inclusive.

SEC source: 0001474506-25-000145 · primary_doc.xml · nonDerivative · entry 11

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 399,407

F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) through (21) to this Form 4.

F9 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.575 to $2.860, inclusive.

SEC source: 0001474506-25-000145 · primary_doc.xml · nonDerivative · entry 10

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 396,807

SEC source: 0001474506-25-000145 · primary_doc.xml · nonDerivative · entry 9

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 396,707

F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) through (21) to this Form 4.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.525 to $2.574, inclusive.

SEC source: 0001474506-25-000145 · primary_doc.xml · nonDerivative · entry 8

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 396,057

F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) through (21) to this Form 4.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.551 to $2.688, inclusive.

SEC source: 0001474506-25-000145 · primary_doc.xml · nonDerivative · entry 7

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 395,457

F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) through (21) to this Form 4.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.608 to $2.615, inclusive.

SEC source: 0001474506-25-000145 · primary_doc.xml · nonDerivative · entry 6

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 395,057

F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) through (21) to this Form 4.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.200 to $2.750, inclusive.

SEC source: 0001474506-25-000145 · primary_doc.xml · nonDerivative · entry 5

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 384,757

F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) through (21) to this Form 4.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.210 to $2.240, inclusive.

SEC source: 0001474506-25-000145 · primary_doc.xml · nonDerivative · entry 4

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 384,157

SEC source: 0001474506-25-000145 · primary_doc.xml · nonDerivative · entry 3

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 384,057

F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) through (21) to this Form 4.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.080 to $2.340, inclusive.

SEC source: 0001474506-25-000145 · primary_doc.xml · nonDerivative · entry 2

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 383,607

SEC source: 0001213900-25-054279 · ownership.xml · derivative · entry 1

Knight Therapeutics Inc · CIK 0001756235 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 428,570

Underlying: Common Stock · 428,570 shares

Expires not disclosed

F1 · derivative.exercise_price: The Pre-Funded Common Stock Purchase Warrants (the "Warrants") are exercisable by the holder at any time on or after June 11, 2025 at an exercise price equal to $0.00001 per share, subject to adjustments as provided under the terms of the Warrant, subject to a post-exercise beneficial ownership limitation of 19.90% ("Beneficial Ownership Limitation").

F1 · derivative.exercise_date: The Pre-Funded Common Stock Purchase Warrants (the "Warrants") are exercisable by the holder at any time on or after June 11, 2025 at an exercise price equal to $0.00001 per share, subject to adjustments as provided under the terms of the Warrant, subject to a post-exercise beneficial ownership limitation of 19.90% ("Beneficial Ownership Limitation").

F2 · derivative.expiration_date: The Warrants will expire on June 11, 2026 with automatic extensions of one year each in case the Warrants have not been exercised in full due to the Beneficial Ownership Limitation.

F3 · ownership.nature: The 428,570 Warrants are held by Knight Therapeutics International S.A. ("Knight Subsidiary"), a wholly-owned subsidiary of the Reporting Person. The Reporting Person is the sole owner of Knight Subsidiary and, as a result, may be deemed the beneficial owner for purposes of the U.S. Securities Exchange Act of 1934 ("Act") of any securities of Issuer beneficially owned by Knight Subsidiary. The Reporting Person disclaims beneficial ownership over all of the securities beneficially owned by Knight Subsidiary, other than for the purpose of determining obligations under the Act, and the filing of this Form 4 shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for any other purpose.

SEC source: 0001474506-25-000145 · primary_doc.xml · nonDerivative · entry 1

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 383,507

F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) through (21) to this Form 4.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.173 to $2.198, inclusive.

SEC source: 0001474506-25-000110 · primary_doc.xml · nonDerivative · entry 6

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 382,607

F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) through (7) to this Form 4.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.110 to $2.200, inclusive.

SEC source: 0001474506-25-000110 · primary_doc.xml · nonDerivative · entry 5

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 381,407

F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) through (7) to this Form 4.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.110 to $2.180, inclusive.

SEC source: 0001474506-25-000110 · primary_doc.xml · nonDerivative · entry 4

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 380,707

F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) through (7) to this Form 4.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.990 to $2.070, inclusive.

SEC source: 0001474506-25-000110 · primary_doc.xml · nonDerivative · entry 3

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 379,907

F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) through (7) to this Form 4.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.026 to $2.130, inclusive.

SEC source: 0001474506-25-000110 · primary_doc.xml · nonDerivative · entry 2

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 378,307

F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) through (7) to this Form 4.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.738 to $1.888, inclusive.

SEC source: 0001474506-25-000110 · primary_doc.xml · nonDerivative · entry 1

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 368,907

F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) through (7) to this Form 4.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.714 to $1.760, inclusive.

SEC source: 0001474506-25-000106 · primary_doc.xml · nonDerivative · entry 12

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 366,507

F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Ex-change Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) through (9) to this Form 4.

F9 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.116 to $2.180, inclusive.

SEC source: 0001474506-25-000106 · primary_doc.xml · nonDerivative · entry 11

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 366,007

SEC source: 0001474506-25-000106 · primary_doc.xml · nonDerivative · entry 10

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 365,907

F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Ex-change Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) through (9) to this Form 4.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.821 to $1.968, inclusive.

SEC source: 0001474506-25-000106 · primary_doc.xml · nonDerivative · entry 9

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 364,907

F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Ex-change Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) through (9) to this Form 4.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.827 to $1.830, inclusive.

SEC source: 0001474506-25-000106 · primary_doc.xml · nonDerivative · entry 8

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 364,607

SEC source: 0001474506-25-000106 · primary_doc.xml · nonDerivative · entry 7

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 364,507

F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Ex-change Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) through (9) to this Form 4.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.043 to $2.174, inclusive.

SEC source: 0001474506-25-000106 · primary_doc.xml · nonDerivative · entry 6

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 363,707

F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Ex-change Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) through (9) to this Form 4.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.025 to $2.093, inclusive.

SEC source: 0001474506-25-000106 · primary_doc.xml · nonDerivative · entry 5

Ross Jack · CIK 0001626921 · Director · CEO and Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 362,807

F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Synergy CHC Corp., any security holder of Synergy CHC Corp., or the staff of the Securities and Ex-change Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) through (9) to this Form 4.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.413 to $2.468, inclusive.